CRA’s Life Sciences Practice is a sponsor of this conference.
For more information on this event, click here.
Strategies for combination therapy in oncology: Part two – Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe. In...